Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update

Go back to Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
(NASDAQ: CMPX) Delayed: 2.06 -0.04 (1.9%)
Previous Close $2.10    52 Week High
Open $2.04    52 Week Low
Day High $2.11    P/E N/A 
Day Low $2.04    EPS
Volume 3,098,091